Loading the section…
The price of PharmaCyte Biotech, Inc. (PMCB) on October 9, 2026 is 0.4044 USD, +1.76% on the day. Over 52 weeks the stock traded between 0.3339 USD and 1.51 USD; the price now sits 6% of the way up that range. Over the past year the price changed by −60.35%. Market capitalization is 4.34 million USD, rank 123 among 128 stocks of the same industry with a known capitalization.
Closing prices for 9 October 2026
Next earnings report: none scheduled in the next five weeks · Earnings calendar
Change over the period shown (line colour): −59.56 %
PharmaCyte Biotech, Inc. trades on Nasdaq under the ticker PMCB. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks PMCB has traded between 0.3339 $ and 1.51 $. As of 9 October 2026 the price stood 5.99 % of the way from the 52-week low to the high.
Over one year PMCB shares fell 60.35 %; over six months they fell 38.08 %. Volatility over 90 days is 60.60 %. Dividends are not included: this is price change only, as of 9 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to book is 0.1, below the sector median of 2.5. Calculated from reports for the period ending 31 January 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 0.4082 | 0.4149 | 0.3910 | 0.4044 | 93,500 |
| 8 October 2026 | 0.4073 | 0.4219 | 0.3865 | 0.3974 | 214,100 |
| 7 October 2026 | 0.4170 | 0.4220 | 0.4011 | 0.4056 | 97,500 |
| 6 October 2026 | 0.3900 | 0.4442 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 January 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
No events for this security recently.
Address:3960 HOWARD HUGHES PARKWAY SUITE 500, LAS VEGAS, NV, 89169, US
PharmaCyte Biotech, Inc. reported revenue of 0 $ and a net loss of 3M $ over the last four quarters. Earnings per share are −0.89 $. Market capitalisation is 4M $.
PMCB has a return on equity of −8.61 %, above the sector median of −41.68 %. Return on assets is −5.87 %, above the sector median of −32.11 %.
| 428M |
| RVMDRevolution Medicines, Inc. | 189.76 | +0.87 % | 409M |
| HALOHalozyme Therapeutics, Inc. | 110.42 | +0.53 % | 253M |
| BIIBBiogen Inc. | 225.71 | +3.33 % | 227M |
| KODKodiak Sciences Inc | 99.87 | +5.95 % | 219M |
| 0.3900 |
| 0.4224 |
| 232,100 |
| 5 October 2026 | 0.4000 | 0.4096 | 0.3851 | 0.3901 | 73,600 |
| 2 October 2026 | 0.4081 | 0.4248 | 0.4001 | 0.4001 | 41,700 |
| 1 October 2026 | 0.4179 | 0.4384 | 0.4017 | 0.4039 | 82,700 |
| 30 September 2026 | 0.4200 | 0.4398 | 0.4081 | 0.4106 | 193,300 |
| 29 September 2026 | 0.4280 | 0.4467 | 0.4190 | 0.4190 | 110,800 |
| 28 September 2026 | 0.4380 | 0.4380 | 0.4108 | 0.4199 | 140,300 |
| 25 September 2026 | 0.4510 | 0.4740 | 0.4400 | 0.4410 | 399,500 |
| 24 September 2026 | 0.4280 | 0.4657 | 0.4280 | 0.4564 | 288,600 |
| 23 September 2026 | 0.4400 | 0.4580 | 0.4217 | 0.4285 | 241,000 |
| 22 September 2026 | 0.4443 | 0.4622 | 0.4442 | 0.4585 | 98,100 |
| 21 September 2026 | 0.4600 | 0.4600 | 0.4401 | 0.4508 | 100,500 |
| 18 September 2026 | 0.4120 | 0.4776 | 0.4089 | 0.4597 | 468,800 |
| 17 September 2026 | 0.4110 | 0.4480 | 0.4012 | 0.4240 | 457,500 |
| 16 September 2026 | 0.3750 | 0.5000 | 0.3750 | 0.4162 | 3M |
| 15 September 2026 | 0.3801 | 0.4151 | 0.3339 | 0.3823 | 1M |
| 14 September 2026 | 0.4415 | 0.4519 | 0.3500 | 0.3920 | 596,900 |